Sarcoidosis: Clinical course and prognostic predictors

O. Tolokh, N. Rudnycka, U. Chulovska (Ukraine)

Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Session: Management of sarcoidosis and lung manifestations of systemic diseases
Session type: Thematic Poster Session
Number: 592
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Tolokh, N. Rudnycka, U. Chulovska (Ukraine). Sarcoidosis: Clinical course and prognostic predictors. Eur Respir J 2010; 36: Suppl. 54, 592

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic predictors of course sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

Relevant prognostic predictors of sarcoidosis course
Source: Eur Respir J 2001; 18: Suppl. 33, 345s
Year: 2001

Thymoma: Clinical features and prognostic factors in 47 patients
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013

Prognostic impact and clinical characteristics of Interstitial Pneumonia with Autoimmune features (IPAF) in a multidisciplinary setting
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Predicting the course of sarcoidosis with clinical factors
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Lung transplantation for sarcoidosis: outcome and prognostic factors
Source: Eur Respir J, 58 (2) 2003358; 10.1183/13993003.03358-2020
Year: 2021



Predictive value of clinical diagnosis in sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 345s
Year: 2001

Tuberculosis in the elderly: clinical presentation and outcome
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007


Sarcoidosis: imagiological findings and their impact on the disease outcome
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


Outcome predictive factors in patients with sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017


Community acquired pneumonia in the elderly: clinical aspects and prognostic factors
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

The Profile of Sarcoidosis in Greece: Clinical characteristics, Extra-pulmonary manifestations, Long-term Follow-up
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020


The prognostic value of some clinical and laboratory parameters in sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 434s
Year: 2002

Diagnostic and prognostic value of advanced imaging modalities in patients with suspected cardiac sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Clinical and laboratory parameters to categorise Sarcoidosis
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Atopy in sarcoidosis a good prognostic sign?
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015


Sarcoidosis in Israel: Clinical outcome status, organ involvement and long term follow up
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017

Independent prognostic factors and prognostic classifications: how can we predict survival on the basis of clinical, pathological and routine biological factors?
Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer
Year: 2011


Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018